Health

UNICEF and Rönesans Partner to Transform Youth Vocational Education in Türkiye

ISTANBUL, Dec. 1, 2025 /PRNewswire/ -- Rönesans Holding, has announced its role as a major private sector partner in UNICEF's "From Learning to Earning for Youth" programme. In collaboration with the Ministry of National Education, this bold initiative is set to reimagine vocational education for...

2025-12-01 21:02

KPJ Healthcare launches first Centre of Excellence at Johor Specialist Hospital, advancing KPJ Health System in collaboration with Mayo Clinic Global Consulting

JOHOR BAHRU, Malaysia, Dec. 1, 2025 /PRNewswire/ -- KPJ Healthcare Berhad ("KPJ Healthcare" or "the Group") today launched its first Centre of Excellence ("CoE") under the KPJ Health System ("KPJHS"), marking a decisive step in the Group's transformation into an integrated academic health system....

2025-12-01 20:49

Generate:Biomedicines to Initiate Global Phase 3 Studies of GB-0895, a Long-Acting Anti-TSLP Antibody for Severe Asthma Engineered with AI

SOLAIRIA-1 and SOLAIRIA-2 will evaluate GB-0895 in approximately 1,600 patients with severe asthma whose disease remains inadequately controlled on current therapies These are the first global Phase 3 studies of a long-acting anti-TSLP antibody, marking a pivotal step as GB-0895 advances the pro...

2025-12-01 19:00 308

Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po

HONG KONG, Dec. 1, 2025 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited (" Lee's Pharm" or the "Group", stock code: 0950.HK) expresses its deep condolences to the victims of the serious fire at Wang Fuk Court inTai Po, which caused multiple casualties and left many residents homeless and in ...

2025-12-01 18:46 368

CooperVision Opens Regional Service Centre in partnership with CEVA Logistics to Accelerate Asia Pacific Growth.

Driving faster delivery and broader portfolio access across the region. SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- CooperVision Asia Pacific, in collaboration with CEVA Logistics, has opened a new Regional Service Centre in Singapore, marking a significant milestone in both companies' commitment to ...

2025-12-01 17:10 602

Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool

Asia-led, "sovereign-by-design" platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide faster "time to actionable insight" of outbreaks, from detection to control measures being in place. SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- ...

2025-12-01 17:10 584

Medit recognized as the top brand in a global brand perception study by an external insights agency

Global sentiment analysis of 3,800 discussions from Reddit's r/Dentistry community highlights strong user recognition in software usability, workflow flexibility, and overall value. SEOUL, South Korea, Dec. 1, 2025 /PRNewswire/ -- Medit, a leading digital dentistry company, has been ranked as th...

2025-12-01 16:00 365

Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund

COPENHAGEN, Denmark, Dec. 1, 2025 /PRNewswire/ -- Danish diabetes‑tech company Hedia is implementing a leadership change effective1 December 2025, when Rasmus Kofoed will take over as Chief Executive Officer (CEO). He succeeds Lars Christian Lund, who after approximately 2 years in the role has d...

2025-12-01 16:00 332

The Wisdom Derived from the Great Migration: Hakka Medicine - The Unique "Medical Epic" of the Hakka People

HONG KONG, Dec. 1, 2025 /PRNewswire/ -- From November 23rd to 25th, the 7th World Hakka Conference was held in Meizhou,Guangdong. With the theme "Gathering Global Hakka Businesspeople to Foster High-Quality Development," the conference adhered to the principles of "openness, innovation, cooperati...

2025-12-01 15:26 415

Fujitsu develops multi-AI agent collaboration technology to optimize supply chains, launches joint trials

Securely connecting AI agents across multiple companies for rapid response to changing circumstances KAWASAKI, Japan, Dec. 1, 2025 /PRNewswire/ -- Fujitsu Limited today announced the development of a multi-AI agent collaboration technology...

2025-12-01 15:24 418

Oxford Instruments launches Imaris 11: boosting research productivity with clear, workflow-driven image analysis

LONDON, Dec. 1, 2025 /PRNewswire/ -- Oxford Instruments announces the release of Imaris 11, the latest generation of its industry-leading 3D/4D microscopy image visualisation and analysis software. The new version introduces an intuitive Workflow system, enhanced batch processing, and advanced to...

2025-12-01 09:00 642

MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand

SINGAPORE, Dec. 1, 2025 /PRNewswire/ -- MetaOptics Ltd (Catalist: 9MT) (" MetaOptics" or the "Company", and together with its subsidiaries, the "Group"), a leading-edge semiconductor optics company, announced that it is proposing to raiseS$4.85 million through a placement of 6,685,028 new ordinary...

2025-12-01 08:30 561

The Science of Longevity: Inside Prof. Mike Chan's Vision for Living Stronger, Smarter, and Longer

BANGKOK, Dec. 1, 2025 /PRNewswire/ -- Malaysia had a rare moment of reflection this year when former Prime Minister Tun Dr. Mahathir Mohamad turned 100. His milestone sparked public conversations about aging, vitality, and what it truly means to remain strong at any age.

2025-12-01 00:57 798

The Bioregenerative Sports Revolution: How Prof. Mike Chan Is Changing Athlete Recovery -- From Sabah to the Super Bowl

KOTA KINABALU, Malaysia, Dec. 1, 2025 /PRNewswire/ -- Big changes often start in small ways. For Sabah FC, a top Malaysian football club, it began with a simple agreement — a partnership with European Wellness, a medical group best known for anti-aging and precursor stem cell therapy.

2025-12-01 00:27 930

Perlis Royalty Join Prof. Mike Chan in Strengthening Malaysia's Fight Against Autism

KUALA LUMPUR, Malaysia, Nov. 30, 2025 /PRNewswire/ -- Malaysia's drive to modernize autism care received strong support today when the Raja Muda of Perlis, Tuanku Syed Faizuddin Putra Jamalullail, and his consort, Tuanku Dr. Hajah Lailatul Shahreen Akashah Khalil, attended the International Congr...

2025-12-01 00:07 830

Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

-  Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to...

2025-11-30 18:15 804

Qiming Venture Partners Donates HK$3 Million to Tai Po Wang Fuk Court Aid Fund for Post-Fire Recovery

SHANGHAI, Nov. 30, 2025 /PRNewswire/ -- On the afternoon of November 26, a major Grade 5 fire spread across multiple residential buildings inWang Fuk Court inTai Po, Hong Kong, causing severe casualties and drawing widespread public concern. In response, onNovember 28, Qiming Venture Partners mad...

2025-11-30 07:17 1223

ANKH Pain Relief Health Group Donates HK$1 Million to the Hong Kong Red Cross To Support Disaster Relief Efforts

HONG KONG, Nov. 29, 2025 /PRNewswire/ -- In response to the devastating No. 5 alarm fire at Wang Fuk Court,Tai Po, ANKH Pain Relief Health Group has donated HK$1 million to the Hong Kong Red Cross to support their "Tai Po Fire Emergency Appeal". The major blaze at Wang Fuk Court has caused serio...

2025-11-29 08:00 1848

Angel Yeast's 8,500-Ton Specialty Yeast Facility and New Brewing Microbial Pilot Platform Come Online

YICHANG, China, Nov. 28, 2025 /PRNewswire/ -- Angel Yeast (SH600298), a global leader in yeast and fermentation solutions, has begun trial production at its new specialty yeast project in the Baiyang Biotechnology Park, Yichang High‑tech Zone. The facility commenced m...

2025-11-28 20:58 597

Inaticabtagene Autoleucel (YORWIDATM) New Drug Application for Lymphoma Approved, China's innovative CAR-T Enters a New Era of Dual Indications

BEIJING, Nov. 28, 2025 /PRNewswire/ -- On November 28, 2025, Juventas Cell Therapy Co., Ltd. (hereinafter referred to as "Juventas") announced that its independently developed CAR-T cell therapy product, Inaticabtagene Autoleucel ( Ina-cel) (tradename: YORWIDATM), has received new drug marketing a...

2025-11-28 20:52 595
12345 ... 563